TY - STD TI - The Hon Sussan Ley MP. Minister for Health. In: Press release: Turnbull Govt invests over $1 billion to cure hep C. Canberra: ACT; 2015 ID - ref1 ER - TY - STD TI - World Health Organization. Combating hepatitis B and C to reach elimination by 2030. Geneva, Switzerland. 2016 ID - ref2 ER - TY - STD TI - The Kirby Institute. Monitoring hepatitis C treatment uptake in Australia (Issue 8). The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; 2017. Available at: https://kirby.unsw.edu.au/report/monitoring-hepatitis-c-treatment-uptake-australia-issue-8-december-2017 UR - https://kirby.unsw.edu.au/report/monitoring-hepatitis-c-treatment-uptake-australia-issue-8-december-2017 ID - ref3 ER - TY - STD TI - Whiteley D, Whittaker A, Elliott L, Cunningham-Burley S. Hepatitis C in a new therapeutic era: Recontextualising the lived experience. J Clin Nurs. 2017 ID - ref4 ER - TY - JOUR AU - Mah, A. AU - Hull, M. W. AU - DeBeck, K. PY - 2017 DA - 2017// TI - Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals JO - Int J Drug Policy. VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.02.006 DO - 10.1016/j.drugpo.2017.02.006 ID - Mah2017 ER - TY - JOUR AU - Whiteley, D. AU - Whittaker, A. AU - Elliott, L. AU - Cunningham-Burley, S. PY - 2016 DA - 2016// TI - The lived experience of interferon-free treatments for hepatitis C: a thematic analysis JO - Int J Drug Policy. VL - 38 UR - https://doi.org/10.1016/j.drugpo.2016.10.013 DO - 10.1016/j.drugpo.2016.10.013 ID - Whiteley2016 ER - TY - STD TI - Anti-Discrimination Board of New South Wales. C change. In: Report of the enquiry into hepatitis C related discrimination. Sydney, Anti-Discrimination Board of New South Wales; 2001. Retrieved from http://www.antidiscrimination.justice.nsw.gov.au/Documents/hepc_report.pdf. UR - http://www.antidiscrimination.justice.nsw.gov.au/Documents/hepc_report.pdf ID - ref7 ER - TY - JOUR AU - Dowsett, L. E. AU - Coward, S. AU - Lorenzetti, D. L. AU - MacKean, G. AU - Clement, F. PY - 2017 DA - 2017// TI - Living with hepatitis C virus: a systematic review and narrative synthesis of qualitative literature JO - Can J Gastroenterol Hepatol VL - 2017 UR - https://doi.org/10.1155/2017/3268650 DO - 10.1155/2017/3268650 ID - Dowsett2017 ER - TY - JOUR AU - Younossi, Z. AU - Park, H. AU - Henry, L. AU - Adeyemi, A. AU - Stepanova, M. PY - 2016 DA - 2016// TI - Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden JO - Gastroenterology VL - 150 UR - https://doi.org/10.1053/j.gastro.2016.02.039 DO - 10.1053/j.gastro.2016.02.039 ID - Younossi2016 ER - TY - JOUR AU - Lee, M. H. AU - Yang, H. I. AU - Lu, S. N. PY - 2012 DA - 2012// TI - Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study JO - J Infect Dis VL - 206 UR - https://doi.org/10.1093/infdis/jis385 DO - 10.1093/infdis/jis385 ID - Lee2012 ER - TY - JOUR AU - Negro, F. AU - Forton, D. AU - Craxì, A. AU - Sulkowski, M. S. AU - Feld, J. J. AU - Manns, M. P. PY - 2015 DA - 2015// TI - Extrahepatic morbidity and mortality of chronic hepatitis C JO - Gastroenterology VL - 149 UR - https://doi.org/10.1053/j.gastro.2015.08.035 DO - 10.1053/j.gastro.2015.08.035 ID - Negro2015 ER - TY - STD TI - Wallace J, Richmond JA, Ellard J, Power J, Lucke J. Eradicating hepatitis C: the need for a public health response. Global Public Health. 2017:1–11. ID - ref12 ER - TY - JOUR AU - Bonkovsky, H. L. AU - Woolley, J. M. PY - 1999 DA - 1999// TI - Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy JO - The Consensus Interferon Study Group Hepatology VL - 29 ID - Bonkovsky1999 ER - TY - JOUR AU - Gonzalez, H. C. AU - Duarte-Rojo, A. PY - 2016 DA - 2016// TI - Virologic cure of hepatitis C: impact on hepatic fibrosis and patient outcomes JO - Curr Gastroenterol Rep VL - 18 UR - https://doi.org/10.1007/s11894-016-0508-y DO - 10.1007/s11894-016-0508-y ID - Gonzalez2016 ER - TY - JOUR AU - Arase, Y. AU - Suzuki, F. AU - Suzuki, Y. PY - 2009 DA - 2009// TI - Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C JO - Hepatology VL - 49 UR - https://doi.org/10.1002/hep.22703 DO - 10.1002/hep.22703 ID - Arase2009 ER - TY - JOUR AU - Byrnes, V. AU - Miller, A. AU - Lowry, D. PY - 2012 DA - 2012// TI - Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition JO - J Hepatol VL - 56 UR - https://doi.org/10.1016/j.jhep.2011.09.015 DO - 10.1016/j.jhep.2011.09.015 ID - Byrnes2012 ER - TY - JOUR AU - Hsu, Y. C. AU - Ho, H. J. AU - Huang, Y. T. PY - 2015 DA - 2015// TI - Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection JO - Gut VL - 64 UR - https://doi.org/10.1136/gutjnl-2014-308163 DO - 10.1136/gutjnl-2014-308163 ID - Hsu2015 ER - TY - STD TI - Younossi ZM, Stepanova M, Esteban R, et al. Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity. Medicine (Baltimore). 2017;96(7):e5914. ID - ref18 ER - TY - STD TI - Lane S, Cline S, Szabo S, Beusterien K, Hautamaki E, Bernstein D, Liu Y et al. P20: Understanding the impact of a cure for hepatitis C from the patient perspective. Journal of Viral Hepatitis - Special Issue: Abstracts for the Viral Hepatitis Congress 2013, 26–28 September 2013, Frankfurt, Germany; 20(Suppl s3):27–28. ID - ref19 ER - TY - JOUR AU - Goutzamanis, S. AU - Doyle, J. S. AU - Thompson, A. AU - Dietze, P. AU - Hellard, M. AU - Higgs, P. PY - 2017 DA - 2017// TI - The impact of hepatitis C-related uncertainty on self-reported stress in people who inject drugs living with hepatitis C JO - J Virus Eradication VL - 3 ID - Goutzamanis2017 ER - TY - JOUR AU - Harris, M. PY - 2017 DA - 2017// TI - Managing expense and expectation in a treatment revolution: problematizing prioritisation through an exploration of hepatitis C treatment ‘benefit’ JO - Int J Drug Policy VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.03.015 DO - 10.1016/j.drugpo.2017.03.015 ID - Harris2017 ER - TY - JOUR AU - Treloar, C. AU - Rance, J. AU - Backmund, M. PY - 2013 DA - 2013// TI - Understanding barriers to hepatitis C virus care and stigmatization from a social perspective JO - Clin Infect Dis VL - 57 UR - https://doi.org/10.1093/cid/cit263 DO - 10.1093/cid/cit263 ID - Treloar2013 ER - TY - BOOK PY - 2015 DA - 2015// TI - We live with it almost every day of our lives – an AIVL report into experiences of Stigma & Discrimination PB - AIVL CY - Canberra ID - ref23 ER - TY - JOUR AU - Hajarizadeh, B. AU - Grebely, J. AU - McManus, H. PY - 2017 DA - 2017// TI - Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment JO - J Gastroenterol Hepatol VL - 32 UR - https://doi.org/10.1111/jgh.13453 DO - 10.1111/jgh.13453 ID - Hajarizadeh2017 ER - TY - JOUR AU - Konerman, M. A. AU - Thomson, M. AU - Gray, K. PY - 2017 DA - 2017// TI - Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers JO - Hepatology VL - 66 UR - https://doi.org/10.1002/hep.29362 DO - 10.1002/hep.29362 ID - Konerman2017 ER - TY - STD TI - Rogers, E. Diffusion of Innovations. 2003, 5th edition. Simon and Schuster, New York. ID - ref26 ER - TY - JOUR AU - Grebely, J. AU - Knight, E. AU - Genoway, K. A. PY - 2010 DA - 2010// TI - Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support JO - Eur J Gastroenterol Hepatol VL - 22 UR - https://doi.org/10.1097/MEG.0b013e32832a8c4c DO - 10.1097/MEG.0b013e32832a8c4c ID - Grebely2010 ER - TY - JOUR AU - Bonnington, O. AU - Harris, M. PY - 2017 DA - 2017// TI - Tensions in relation: how peer support is experienced and received in a hepatitis C treatment intervention JO - Int J Drug Policy VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.05.031 DO - 10.1016/j.drugpo.2017.05.031 ID - Bonnington2017 ER - TY - JOUR AU - Crawford, S. AU - Bath, N. PY - 2013 DA - 2013// TI - Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection JO - Clin Infect Dis VL - 57 UR - https://doi.org/10.1093/cid/cit297 DO - 10.1093/cid/cit297 ID - Crawford2013 ER - TY - JOUR AU - Norman, J. AU - Walsh, N. M. AU - Mugavin, J. PY - 2008 DA - 2008// TI - The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug JO - Harm Reduct J VL - 5 UR - https://doi.org/10.1186/1477-7517-5-8 DO - 10.1186/1477-7517-5-8 ID - Norman2008 ER - TY - JOUR AU - Richmond, J. A. AU - Sheppard-Law, S. AU - Mason, S. AU - Warner, S. W. PY - 2016 DA - 2016// TI - The Australasian Hepatology association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals JO - Patient Preference and Adherence VL - 10 UR - https://doi.org/10.2147/PPA.S117757 DO - 10.2147/PPA.S117757 ID - Richmond2016 ER - TY - JOUR AU - Goutzamanis, S. AU - Doyle, J. AU - Thompson, A. AU - Hellard, M. AU - Higgs, P. PY - 2016 DA - 2016// TI - Direct-acting antiviral treatment for HCV JO - The Lancet – Infectious Diseases VL - 16 UR - https://doi.org/10.1016/S1473-3099(16)30403-0 DO - 10.1016/S1473-3099(16)30403-0 ID - Goutzamanis2016 ER -